Ipratropium bromide in children with asthma.
نویسندگان
چکیده
منابع مشابه
Ipratropium bromide in children with asthma.
Eighteen children between 6 and 14 years of age with perennial asthma were studied over two four-week treatment periods. Ipratropium bromide, given in addition to their current treatment, was compared with placebo using a double-blind crossover technique. The period of treatment with ipratropium was associated with a significant reduction in symptoms during both day and night and significantly ...
متن کاملBronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.
The bronchodilator activity in nebulised salbutamol, ipratropium bromide, clemastine, and a placebo was studied in 14 asthmatic children aged between 3 and 5 years. Changes in lung function were monitored by measuring peak expiratory flow rate and total respiratory resistance using a modification of the forced oscillation technique. Ipratropium bromide produced a degree of bronchodilation simil...
متن کاملBronchial responsiveness to hyperventilation in children with asthma: inhibition by ipratropium bromide.
Isocapnic hyperventilation dose response curves were constructed for 11 asthmatic children before and after pretreatment with placebo or ipratropium bromide, 40-1500 micrograms given by inhalation, on three separate days. The response before and after placebo was highly reproducible (within subject coefficient of variation 7.5%, 18%, and 22% for intervals of two hours, within two weeks, and ove...
متن کاملIpratropium bromide plus nebulized albuterol for the treatment of hospitalized children with acute asthma.
OBJECTIVE To determine whether the addition of repeated doses of nebulized ipratropium bromide (IB) to a standardized inpatient asthma care algorithm (ACA) for children with status asthmaticus improves clinical outcome. STUDY DESIGN Children with acute asthma (N = 210) age 1 to 18 years admitted to the ACA were assigned to the intervention or placebo group in randomized double-blind fashion. ...
متن کاملIpratropium Bromide plus Nebulized Albuterol for the Treatment of Hospitalized Children with Acute Asthma
were also statistically significant differences in asthma symptom scores and number of puffs of rescue medication in favor of omalizumab. Incidence of adverse effects were similar in placebo and omalizumab groups. Conclusion. These results indicate that omalizumab therapy safely improves asthma control in allergic asthmatics who remain symptomatic despite regular use of inhaled corticosteroids ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Thorax
سال: 1982
ISSN: 0040-6376
DOI: 10.1136/thx.37.1.72